AbbVie to take over Cerevel Therapeutics in $8.7B deal

Dicembre 7, 2023

AbbVie Inc. revealed in a statement it will be acquiring Cerevel Therapeutics Hldg in an agreement valued at $8.7 billion or $45 per share.

The deal is expected to boost AbbVie’s neuroscience por…